nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Oedema—Triamcinolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Vertigo—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Vertigo—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Syncope—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Syncope—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Arrhythmia—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Haematuria—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Shock—Triamcinolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Insomnia—Prednisolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Shock—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Epistaxis—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Mental disorder—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Malnutrition—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Erythema—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Convulsion—Dexamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Convulsion—Betamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Hypertension—Betamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Hypertension—Dexamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Myalgia—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Myalgia—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Anxiety—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Anxiety—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Discomfort—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Haemoglobin—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Pain—Prednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Haemorrhage—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Oedema—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Oedema—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Insomnia—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Shock—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Shock—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Agitation—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Tachycardia—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Malaise—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Vertigo—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Eye disorder—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Syncope—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Tinnitus—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Anorexia—Dexamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Anorexia—Betamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Urticaria—Prednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Pain—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Hypotension—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Hypotension—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Angiopathy—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Immune system disorder—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Convulsion—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Hypertension—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Chills—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Arthralgia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Insomnia—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Insomnia—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Mental disorder—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Erythema—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Malnutrition—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Urticaria—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Fatigue—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Shock—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Pain—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Pain—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Urticaria—Betamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Dizziness—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Rash—Prednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Headache—Prednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Dizziness—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Asthenia—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Asthenia—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Nausea—Prednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Pruritus—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Vomiting—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Rash—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Rash—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Headache—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Headache—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dizziness—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Dizziness—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Nausea—Triamcinolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Nausea—Methylprednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000991	0.000991	CcSEcCtD
Gadoversetamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Gadoversetamide—Vomiting—Betamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000978	0.000978	CcSEcCtD
Gadoversetamide—Rash—Dexamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Gadoversetamide—Rash—Betamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Gadoversetamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Gadoversetamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000972	0.000972	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—psoriatic arthritis	0.00097	0.00097	CcSEcCtD
Gadoversetamide—Headache—Betamethasone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Gadoversetamide—Headache—Dexamethasone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—psoriatic arthritis	0.000966	0.000966	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—psoriatic arthritis	0.000962	0.000962	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—psoriatic arthritis	0.000953	0.000953	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000927	0.000927	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000921	0.000921	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00092	0.00092	CcSEcCtD
Gadoversetamide—Nausea—Dexamethasone—psoriatic arthritis	0.000918	0.000918	CcSEcCtD
Gadoversetamide—Nausea—Betamethasone—psoriatic arthritis	0.000918	0.000918	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—psoriatic arthritis	0.00089	0.00089	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00089	0.00089	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00089	0.00089	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Gadoversetamide—Rash—Prednisone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—psoriatic arthritis	0.000848	0.000848	CcSEcCtD
Gadoversetamide—Headache—Prednisone—psoriatic arthritis	0.000844	0.000844	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—psoriatic arthritis	0.000807	0.000807	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—psoriatic arthritis	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00077	0.00077	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—psoriatic arthritis	0.000744	0.000744	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—psoriatic arthritis	0.000715	0.000715	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—psoriatic arthritis	0.00071	0.00071	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—psoriatic arthritis	0.000705	0.000705	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—psoriatic arthritis	0.000668	0.000668	CcSEcCtD
